{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:00:26Z","timestamp":1773280826646,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2415-14-160","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T06:55:18Z","timestamp":1434610518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bimatoprost 0.01% in treatment-na\u00efve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting"],"prefix":"10.1186","volume":"14","author":[{"given":"Ki Ho","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Simonyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Ho","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Scott","family":"Kook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"521_CR1","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/sj.eye.6701746","volume":"19","author":"HA Quigley","year":"2005","unstructured":"Quigley HA: New paradigms in the mechanisms and management of glaucoma. Eye (Lond). 2005, 19: 1241-1248. 10.1038\/sj.eye.6701746.","journal-title":"Eye (Lond)"},{"key":"521_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT: The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006, 90: 262-267. 10.1136\/bjo.2005.081224.","journal-title":"Br J Ophthalmol"},{"key":"521_CR3","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1167\/iovs.06-0299","volume":"47","author":"AR Rudnicka","year":"2006","unstructured":"Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D: Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci. 2006, 47: 4254-4261. 10.1167\/iovs.06-0299.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"521_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3341\/kjo.2011.25.2.110","volume":"25","author":"JH Kim","year":"2011","unstructured":"Kim JH, Kang SY, Kim NR, Lee ES, Hong S, Seong GJ, Hong YJ, Kim CY: Prevalence and characteristics of glaucoma among Korean adults. Korean J Ophthalmol. 2011, 25: 110-115. 10.3341\/kjo.2011.25.2.110.","journal-title":"Korean J Ophthalmol"},{"key":"521_CR5","first-page":"1641","volume":"111","author":"A Iwase","year":"2004","unstructured":"Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, Inoue Y, Kitazawa Y: The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology. 2004, 111: 1641-1648.","journal-title":"Ophthalmology"},{"key":"521_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1136\/bjo.2007.128819","volume":"92","author":"K Kawase","year":"2008","unstructured":"Kawase K, Tomidokoro A, Araie M, Iwase A, Yamamoto T: Ocular and systemic factors related to intraocular pressure in Japanese adults: the Tajimi study. Br J Ophthalmol. 2008, 92: 1175-1179. 10.1136\/bjo.2007.128819.","journal-title":"Br J Ophthalmol"},{"key":"521_CR7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.ophtha.2010.10.016","volume":"118","author":"CS Kim","year":"2011","unstructured":"Kim CS, Seong GJ, Lee NH, Song KC: Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology. 2011, 118: 1024-1030. 10.1016\/j.ophtha.2010.10.016.","journal-title":"Ophthalmology"},{"key":"521_CR8","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/archopht.120.10.1286","volume":"120","author":"EJ Higginbotham","year":"2002","unstructured":"Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K, Whitcup SM: One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol. 2002, 120: 1286-1293. 10.1001\/archopht.120.10.1286.","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"521_CR9","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.survophthal.2003.12.019","volume":"49","author":"JS Cohen","year":"2004","unstructured":"Cohen JS, Gross RL, Cheetham JK, VanDenburgh AM, Bernstein P, Whitcup SM: Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension. Surv Ophthalmol. 2004, 49 (Suppl 1): S45-S52.","journal-title":"Surv Ophthalmol"},{"key":"521_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1136\/bjo.2007.128454","volume":"92","author":"RD Williams","year":"2008","unstructured":"Williams RD, Cohen JS, Gross RL, Liu CC, Safyan E, Batoosingh AL: Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4. Br J Ophthalmol. 2008, 92: 1387-1392. 10.1136\/bjo.2007.128454.","journal-title":"Br J Ophthalmol"},{"key":"521_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/IJG.0b013e3181666557","volume":"17","author":"F Aptel","year":"2008","unstructured":"Aptel F, Cucherat M, Denis P: Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials. J Glaucoma. 2008, 17: 667-673. 10.1097\/IJG.0b013e3181666557.","journal-title":"J Glaucoma"},{"key":"521_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF02850157","volume":"21","author":"ST Simmons","year":"2004","unstructured":"Simmons ST, Dirks MS, Noecker RJ: Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials. Adv Ther. 2004, 21: 247-262. 10.1007\/BF02850157.","journal-title":"Adv Ther"},{"key":"521_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ajo.2009.12.003","volume":"149","author":"LJ Katz","year":"2010","unstructured":"Katz LJ, Cohen JS, Batoosingh AL, Felix C, Shu V, Schiffman RM: Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension. Am J Ophthalmol. 2010, 149: 661-671. 10.1016\/j.ajo.2009.12.003. e661","journal-title":"Am J Ophthalmol"},{"key":"521_CR14","first-page":"2097","volume":"6","author":"DR Nixon","year":"2012","unstructured":"Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Crichton AC, Discepola M, Hutnik CM, Yan DB: An observational study of bimatoprost 0.01% in treatment-naive patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial. Clin Ophthalmol. 2012, 6: 2097-2103.","journal-title":"Clin Ophthalmol"},{"key":"521_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2147\/OPTH.S31330","volume":"6","author":"S Pfennigsdorf","year":"2012","unstructured":"Pfennigsdorf S, Ramez O, von Kistowski G, Mader B, Eschstruth P, Frobose M, Thelen U, Spraul C, Schnober D, Cooper H, Laube T: Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension. Clin Ophthalmol. 2012, 6: 739-746.","journal-title":"Clin Ophthalmol"},{"key":"521_CR16","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1001\/jama.284.23.3043","volume":"284","author":"World Medical Association","year":"2000","unstructured":"World Medical Association: World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000, 284: 3043-3045. 10.1001\/jama.284.23.3043.","journal-title":"JAMA"},{"key":"521_CR17","first-page":"1031","volume":"8","author":"AC Crichton","year":"2014","unstructured":"Crichton AC, Nixon DR, Simonyi S, Bhogal M, Sigouin CS, Discepola MJ, Hutnik CM, Baptiste DC, Yan DB: An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan\u00ae RC Early Analysis Review (CLEAR) trial. Clin Ophthalmol. 2014, 8: 1031-1038.","journal-title":"Clin Ophthalmol"},{"key":"521_CR18","first-page":"1699","volume":"6","author":"G Beidoe","year":"2012","unstructured":"Beidoe G, Mousa SA: Current primary open-angle glaucoma treatments and future directions. Clin Ophthalmol. 2012, 6: 1699-1707.","journal-title":"Clin Ophthalmol"},{"key":"521_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group: Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998, 126: 487-497.","journal-title":"Am J Ophthalmol"},{"key":"521_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group: The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998, 126: 498-505.","journal-title":"Am J Ophthalmol"},{"key":"521_CR21","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2147\/OPTH.S36628","volume":"6","author":"T Tsumura","year":"2012","unstructured":"Tsumura T, Yoshikawa K, Suzumura H, Kimura T, Sasaki S, Kimura I, Takeda R: Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. Clin Ophthalmol. 2012, 6: 1547-1552.","journal-title":"Clin Ophthalmol"},{"key":"521_CR22","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2147\/OPTH.S33414","volume":"6","author":"T Mizoguchi","year":"2012","unstructured":"Mizoguchi T, Ozaki M, Unoki K, Dake Y, Eto T, Arai M: A randomized crossover study comparing tafluprost 0.0015% with travoprost 0.004% in patients with normal-tension glaucoma [corrected; published correction appears in Clin Ophthalmol. 2012; 6:1717]. Clin Ophthalmol. 2012, 6: 1579-1584.","journal-title":"Clin Ophthalmol"},{"key":"521_CR23","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2147\/OPTH.S46340","volume":"7","author":"K Inoue","year":"2013","unstructured":"Inoue K, Tanaka A, Tomita G: Effects of tafluprost treatment for 3\u00a0years in patients with normal-tension glaucoma. Clin Ophthalmol. 2013, 7: 1411-1416.","journal-title":"Clin Ophthalmol"},{"key":"521_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3341\/kjo.2005.19.4.297","volume":"19","author":"JY Oh","year":"2005","unstructured":"Oh JY, Park KH: The effect of latanoprost on intraocular pressure during 12\u00a0months of treatment for normal-tension glaucoma. Korean J Ophthalmol. 2005, 19: 297-301. 10.3341\/kjo.2005.19.4.297.","journal-title":"Korean J Ophthalmol"},{"key":"521_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10384-008-0617-8","volume":"53","author":"MH Suh","year":"2009","unstructured":"Suh MH, Park KH, Kim DM: Effect of travoprost on intraocular pressure during 12\u00a0months of treatment for normal-tension glaucoma. Jpn J Ophthalmol. 2009, 53: 18-23. 10.1007\/s10384-008-0617-8.","journal-title":"Jpn J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-14-160\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:20:54Z","timestamp":1548213654000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-14-160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-14-160","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"21 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"160"}}